Eosinophil response in mast cell-deficient W/WV mice.

Area of Science:

• Immunology
• Hematology

Background:

• Cyclophosphamide treatment combined with Toxocara canis infection effectively induces eosinophilia in mice.
• Mast cells play a role in immune responses, but their specific contribution to eosinophilia is not fully understood.

Purpose of the Study:

• To investigate the role of mast cells in mediating peripheral blood eosinophilia induced by cyclophosphamide and T. canis infection.
• To determine if mast cell deficiency affects eosinophil response in bone marrow and peripheral blood.

Main Methods:

• Utilized mast cell-deficient W/WV mice and their normal littermate +/+ mice.
• Administered cyclophosphamide treatment and T. canis infection to induce eosinophilia.
• Performed bone marrow grafting to assess recovery of eosinophil response.
• Assessed eosinophil counts in peripheral blood and bone marrow.
• Evaluated chemotactic reactivity of eosinophils.

Main Results:

• W/WV mice exhibited significantly lower eosinophil responses compared to +/+ mice.
• The defect in eosinophil response was more pronounced in peripheral blood than in bone marrow of W/WV mice.
• Bone marrow grafting completely restored the defective eosinophil response in W/WV mice.
• Eosinophil chemotactic reactivity was comparable between W/WV and +/+ mice.
• Recovery of eosinophil response in bone marrow post-grafting was faster than in peripheral blood.

Conclusions:

• Mast cell-derived factors are essential for mediating peripheral blood eosinophilia.
• While bone marrow produces eosinophils, mast cells are critical for their accumulation in peripheral blood.
• Bone marrow transplantation can restore eosinophil response in mast cell-deficient individuals.